205 related articles for article (PubMed ID: 26021419)
1. Malignant Pleural Mesothelioma : Rationale for a New TNM Classification.
De Laet C; Domen A; Cheung KJ; Meulemans E; Lauwers P; Hendriks JM; Van Schil PE
Acta Chir Belg; 2014; 114(4):245-9. PubMed ID: 26021419
[TBL] [Abstract][Full Text] [Related]
2. The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma.
Rusch VW; Chansky K; Kindler HL; Nowak AK; Pass HI; Rice DC; Shemanski L; Galateau-Sallé F; McCaughan BC; Nakano T; Ruffini E; van Meerbeeck JP; Yoshimura M;
J Thorac Oncol; 2016 Dec; 11(12):2112-2119. PubMed ID: 27687962
[TBL] [Abstract][Full Text] [Related]
3. The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.
Nowak AK; Chansky K; Rice DC; Pass HI; Kindler HL; Shemanski L; Billé A; Rintoul RC; Batirel HF; Thomas CF; Friedberg J; Cedres S; de Perrot M; Rusch VW;
J Thorac Oncol; 2016 Dec; 11(12):2089-2099. PubMed ID: 27687963
[TBL] [Abstract][Full Text] [Related]
4. The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.
Rice D; Chansky K; Nowak A; Pass H; Kindler H; Shemanski L; Opitz I; Call S; Hasegawa S; Kernstine K; Atinkaya C; Rea F; Nafteux P; Rusch VW;
J Thorac Oncol; 2016 Dec; 11(12):2100-2111. PubMed ID: 27687964
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma.
Proto C; Signorelli D; Mallone S; Prelaj A; Lo Russo G; Imbimbo M; Galli G; Ferrara R; Ganzinelli M; Leuzzi G; Greco FG; Calareso G; Botta L; Gatta G; Garassino M; Trama A
Clin Lung Cancer; 2019 Nov; 20(6):e652-e660. PubMed ID: 31377142
[TBL] [Abstract][Full Text] [Related]
6. The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation.
Pass H; Giroux D; Kennedy C; Ruffini E; Cangir AK; Rice D; Asamura H; Waller D; Edwards J; Weder W; Hoffmann H; van Meerbeeck JP; Nowak A; Rusch VW;
J Thorac Oncol; 2016 Dec; 11(12):2082-2088. PubMed ID: 27670823
[TBL] [Abstract][Full Text] [Related]
7. Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma.
Nickell LT; Lichtenberger JP; Khorashadi L; Abbott GF; Carter BW
Radiographics; 2014 Oct; 34(6):1692-706. PubMed ID: 25310424
[TBL] [Abstract][Full Text] [Related]
8. A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group.
Rusch VW
Lung Cancer; 1996 Feb; 14(1):1-12. PubMed ID: 8696713
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Clinical Staging for Patients With Malignant Pleural Mesothelioma.
Gill RR; Yeap BY; Bueno R; Richards WG
J Natl Cancer Inst; 2018 Mar; 110(3):258-264. PubMed ID: 29931180
[TBL] [Abstract][Full Text] [Related]
10. Malignant Pleural Mesothelioma: Diagnosis, Staging, Pitfalls and Follow-up.
Odisio EG; Marom EM; Shroff GS; Wu CC; Benveniste APA; Truong MT; Benveniste MF
Semin Ultrasound CT MR; 2017 Dec; 38(6):559-570. PubMed ID: 29179896
[TBL] [Abstract][Full Text] [Related]
11. Early-stage Clinical Characterization of Malignant Pleural Mesothelioma.
Negi Y; Kuribayashi K; Funaguchi N; Doi H; Mikami K; Minami T; Takuwa T; Yokoi T; Hasegawa S; Kijima T
In Vivo; 2018; 32(5):1169-1174. PubMed ID: 30150440
[TBL] [Abstract][Full Text] [Related]
12. [Malignant mesothelioma. Diagnosis and treatment].
Boutin C; Schlesser M; Frenay C; Germain S
Rev Prat; 1997 Jun; 47(12):1333-9. PubMed ID: 9248101
[TBL] [Abstract][Full Text] [Related]
13. The Controlling Nutritional Status Score Is a Significant Independent Predictor of Poor Prognosis in Patients With Malignant Pleural Mesothelioma.
Takamori S; Toyokawa G; Taguchi K; Edagawa M; Shimamatsu S; Toyozawa R; Nosaki K; Seto T; Hirai F; Yamaguchi M; Shoji F; Okamoto T; Takenoyama M; Ichinose Y
Clin Lung Cancer; 2017 Jul; 18(4):e303-e313. PubMed ID: 28274690
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients - A Taiwanese study.
Wu TH; Lee LJ; Yuan CT; Chen TW; Yang JC
J Formos Med Assoc; 2019 Jan; 118(1 Pt 2):230-236. PubMed ID: 29709339
[TBL] [Abstract][Full Text] [Related]
15. [Molecular heterogeneity of malignant pleural mesotheliomas].
Tranchant R; Montagne F; Jaurand MC; Jean D
Bull Cancer; 2018 Jan; 105(1):35-45. PubMed ID: 29277245
[TBL] [Abstract][Full Text] [Related]
16. Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
Lococo F; Torricelli F; Lang-Lazdunski L; Veronesi G; Rena O; Paci M; Casadio C; Piana S; Novellis P; Di Stefano TS; Ciarrocchi A; Billè A
J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1584-1593.e2. PubMed ID: 31590954
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma.
Liu H; Wu L; Ji K; Wang W
Tumour Biol; 2015 Sep; 36(10):7375-84. PubMed ID: 26361957
[TBL] [Abstract][Full Text] [Related]
18. Staging and response to therapy of malignant pleural mesothelioma.
Heelan R
Lung Cancer; 2004 Aug; 45 Suppl 1():S59-61. PubMed ID: 15261435
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.
Kindler HL; Ismaila N; Armato SG; Bueno R; Hesdorffer M; Jahan T; Jones CM; Miettinen M; Pass H; Rimner A; Rusch V; Sterman D; Thomas A; Hassan R
J Clin Oncol; 2018 May; 36(13):1343-1373. PubMed ID: 29346042
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility of Malignant Pleural Mesothelioma Histopathologic Subtyping.
Brcic L; Vlacic G; Quehenberger F; Kern I
Arch Pathol Lab Med; 2018 Jun; 142(6):747-752. PubMed ID: 29509030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
